Literature DB >> 28749712

Lung cancer screening-low dose CT for lung cancer screening: recent trial results and next steps.

Emma Louise O'Dowd1, David R Baldwin1.   

Abstract

Screening for lung cancer using low-dose CT has already been implemented in North America following the results of the National Lung Screening Trial. Outside North America, clinicians and researchers are addressing issues that may have a major impact on the success of screening programmes by reviewing results of existing trials and by designing new research and pilot programmes. This review summarizes the work that has been done to try to answer the remaining questions and highlights potential barriers which may affect screening uptake and cost-effectiveness.

Entities:  

Mesh:

Year:  2017        PMID: 28749712      PMCID: PMC6350493          DOI: 10.1259/bjr.20170460

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  46 in total

1.  Attitudes towards screening for lung cancer among smokers and their non-smoking counterparts.

Authors:  Gerard A Silvestri; Paul J Nietert; James Zoller; Cindy Carter; David Bradford
Journal:  Thorax       Date:  2006-11-13       Impact factor: 9.139

2.  Analysis of lung cancer incidence in the Nurses' Health and the Health Professionals' Follow-Up Studies using a multistage carcinogenesis model.

Authors:  Rafael Meza; William D Hazelton; Graham A Colditz; Suresh H Moolgavkar
Journal:  Cancer Causes Control       Date:  2007-12-06       Impact factor: 2.506

3.  Screening for lung cancer: yet another problem.

Authors:  Stephen G Spiro
Journal:  Thorax       Date:  2007-02       Impact factor: 9.139

4.  The impact of genotype frequencies on the clinical validity of genomic profiling for predicting common chronic diseases.

Authors:  A Cecile J W Janssens; Ramal Moonesinghe; Quahne Yang; Ewout W Steyerberg; Cornelia M van Duijn; Muin J Khoury
Journal:  Genet Med       Date:  2007-08       Impact factor: 8.822

5.  Multistage carcinogenesis and lung cancer mortality in three cohorts.

Authors:  William D Hazelton; Mark S Clements; Suresh H Moolgavkar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-05       Impact factor: 4.254

6.  The change in excess risk of lung cancer attributable to smoking following smoking cessation: an examination of different analytic approaches using CPS-I data.

Authors:  James D Knoke; David M Burns; Michael J Thun
Journal:  Cancer Causes Control       Date:  2007-11-09       Impact factor: 2.506

7.  Variations in lung cancer risk among smokers.

Authors:  Peter B Bach; Michael W Kattan; Mark D Thornquist; Mark G Kris; Ramsey C Tate; Matt J Barnett; Lillian J Hsieh; Colin B Begg
Journal:  J Natl Cancer Inst       Date:  2003-03-19       Impact factor: 13.506

8.  The Danish randomized lung cancer CT screening trial--overall design and results of the prevalence round.

Authors:  Jesper H Pedersen; Haseem Ashraf; Asger Dirksen; Karen Bach; Hanne Hansen; Phillip Toennesen; Hanne Thorsen; John Brodersen; Birgit Guldhammer Skov; Martin Døssing; Jann Mortensen; Klaus Richter; Paul Clementsen; Niels Seersholm
Journal:  J Thorac Oncol       Date:  2009-05       Impact factor: 15.609

9.  An expanded risk prediction model for lung cancer.

Authors:  Margaret R Spitz; Carol J Etzel; Qiong Dong; Christopher I Amos; Qingyi Wei; Xifeng Wu; Waun Ki Hong
Journal:  Cancer Prev Res (Phila)       Date:  2008-09

10.  The LLP risk model: an individual risk prediction model for lung cancer.

Authors:  A Cassidy; J P Myles; M van Tongeren; R D Page; T Liloglou; S W Duffy; J K Field
Journal:  Br J Cancer       Date:  2007-12-18       Impact factor: 7.640

View more
  7 in total

1.  CXCL4L1 May Help Differentiate Benign from Malignant Pulmonary Lesions and Predicts Prognosis of Patients with Lung Cancer.

Authors:  Lei Zhang; Guangping Li; Hongxin Zhang; Huaqun Liu; Songlin Li; Yanan Wang; Huisheng Qi
Journal:  Cancer Manag Res       Date:  2022-06-07       Impact factor: 3.602

2.  Prevalence, symptom burden and under-diagnosis of chronic obstructive pulmonary disease in Polish lung cancer screening population: a cohort observational study.

Authors:  Aleksandra Undrunas; Piotr Kasprzyk; Aleksandra Rajca; Krzysztof Kuziemski; Witold Rzyman; Tomasz Zdrojewski
Journal:  BMJ Open       Date:  2022-04-11       Impact factor: 2.692

3.  New recommendation and coverage of low-dose computed tomography for lung cancer screening: uptake has increased but is still low.

Authors:  Jiang Li; Sukyung Chung; Esther K Wei; Harold S Luft
Journal:  BMC Health Serv Res       Date:  2018-07-05       Impact factor: 2.655

4.  Differences in lung cancer characteristics and mortality rate between screened and non-screened cohorts.

Authors:  Fu-Zong Wu; Pei-Lun Kuo; Yi-Luan Huang; En-Kuei Tang; Chi-Shen Chen; Ming-Ting Wu; Yun-Pei Lin
Journal:  Sci Rep       Date:  2019-12-18       Impact factor: 4.379

Review 5.  Lung Cancer Screening: Review and 2021 Update.

Authors:  Anuradha Ramaswamy
Journal:  Curr Pulmonol Rep       Date:  2022-04-02

6.  Low-dose CT examination for rib fracture evaluation: A pilot study.

Authors:  Liang Jin; Xiaojun Ge; Fang Lu; Yingli Sun; Cheng Li; Pan Gao; Feng Gao; Ming Li
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

7.  Diagnostic and prognostic value of microRNA-2355-3p and contribution to the progression in lung adenocarcinoma.

Authors:  Yanan Zhao; Wenlong Zhang; Yang Yang; Enyong Dai; Yuansong Bai
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.